Purpose Patients with cancer are increasingly at risk for venous thromboembolism (VTE).
Rates of VTE, however, vary markedly among patients with cancer. Design This review …

Cancer patients are at increased risk of deep vein thrombosis and pulmonary embolism. The
incidence among different groups of cancer patients varies considerably depending on …

Background—Long-term low-molecular-weight heparin (LMWH) is the current standard for
treatment of venous thromboembolism (VTE) in cancer patients. Whether treatment …

Purpose Patients with cancer are at risk of venous thromboembolism (VTE). Tumor-related
factors could help estimate patients' individual risk for VTE. Currently, only scarce …

Background Tissue factor (TF), the physiologic initiator of coagulation, is over-expressed in
pancreatic cancer, and is associated with a pro-coagulant and pro-angiogenic state. We …

Cancer patients are well-known to be at increased risk of venous thromboembolism (VTE).
However, the risk varies widely between patients and over the natural history of malignancy …

Background The effectiveness of mechanical thrombectomy (MT) in cancer-related stroke
(CRS) is largely unknown. This study aims to investigate the clinical and radiological …

Background Acute pulmonary embolism (PE) is a serious clinical condition characterised by
a high mortality rate. Previous studies showed that leukocytosis was associated with …

Background Acute pulmonary embolism is a serious medical condition that has a substantial
global impact. Inflammation plays a role in the pathophysiology and prognosis of acute …

Risk prediction of chemotherapy-associated venous thromboembolism (VTE) is a
compelling challenge in contemporary oncology, as VTE may result in treatment delays …